Background: Umbilical vascular catheters are routinely inserted in critically ill newborn infants in most neonatal intensive care units (NICU). The objectives of this study were to determine ...

Researchers explored the case of a 40-year-old woman with polycythemia vera (PV) who developed a portal vein occlusion 1.5 months postpartum after C-section. As one of the 3 main classic disorders of ...

Portal vein thrombosis (PVT) is a challenging complication in liver cirrhosis, with no currently available sensitive diagnostic markers. This study aimed to investigate the potential of neutrophil ...

The prevalence of Portal Vein Thrombosis (PVT) varies significantly at different stages of liver disease: 10% in compensated patients, 17% in decompensated patients, 9% in those with acute ...

In conclusion, most patients had a combination of local and systemic risk factors for PVT. We observed that partial/complete recanalization was more frequent in patients treated with anticoagulation ...

Portal vein thrombosis (PVT) is a critical complication in liver cirrhosis (LC), significantly worsening portal hypertension and accelerating the progression to decompensation. Early identification of ...

Comparison of immune checkpoint inhibitor monotherapy versus Sorafenib in unresectable hepatocellular carcinoma. This is an ASCO Meeting Abstract from the 2022 ASCO Annual Meeting I. This abstract ...

Postoperative adjuvant therapy with donafenib in hepatocellular carcinoma with high-risk recurrence factors: A real-world, prospective, observational study. This is an ASCO Meeting Abstract from the ...

Actively identifying the risk factors and predictive indicators associated with portal vein thrombosis (PVT) in liver cirrhosis (LC) can enable early diagnosis and treatment, which is of great ...